Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.
D001806:Blood Urea Nitrogen; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003404:Creatinine / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy; D009447:Neuroblastoma / Q000188:drug therapy; D013945:Thymoma / Q000188:drug therapy; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D003404:Creatinine; D002945:Cisplatin